XTransfer
  • Products & Services
  • About Us
  • Help & Support
English
Create account

Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances

HS Code: 2933990092

SECTION 6

PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES

CHAPTER 29

Organic chemicals

HEADING 2933

 Heterocyclic compounds with nitrogen heteroatom（s）only;

HS Code Structure Breakdown

LevelCodeDescription
Section6PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
Chapter29Organic chemicals
Heading2933 Heterocyclic compounds with nitrogen heteroatom（s）only;
Subheading293399Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances
Commodity2933990092Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances
Advertisement banner

Pay and get paid in local currency. Save up to 80% on your currency exchanges.

Get it for free now

HS Code 2933990092 for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances

Product Wiki

Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.

Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances, with its export volume maintaining a high level over the long term.

Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances.

With technological advancements and the diversification of market demands, the scope of application for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances continues to expand, driving the development of related industries.

Currently, the global supply-demand balance of Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.

Partner

OCBC
DBS
BANK OF CHINA

Our licenses

China

China

HK MSO License

HK MSO License

Singapore

Singapore

UK API License

UK API License

Netherlands

Netherlands

US MSB

US MSB

CA MSB

CA MSB

AU RSP

AU RSP

HS Code FAQ

What is the HS code for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances? Which HS classification does it belong to?

The HS code for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances is 2933990092. This product is classified under: Section 6, Chapter 29 (if applicable, otherwise not shown), Heading 2933 (if applicable, otherwise not shown). This code is used in international trade for the standardized classification and customs declaration of Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances.

What are the import VAT rate and export tax rebate rate for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances?

The import VAT rate and export tax rebate rate for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances depend on its specific HS Code, product category, and the latest customs tariff policies. In general, import VAT rates may fall under different brackets such as 13% or 9%, while export tax rebate rates may vary between 0%, 9%, and 13%. Different products are subject to different tax regulations and rebate policies. Please refer to the latest information released by customs and tax authorities for the most accurate rates.

Is the HS code for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances the same across different countries?

The HS code for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances under the internationally standardized HS coding system is 2933990092, but some countries may use different suffix extensions. It is recommended to confirm based on the customs regulations of the destination country.

How can I confirm whether Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances corresponds to the correct HS code?

You can determine this by checking the function, material, and usage of Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances, and verifying whether the corresponding HS code matches the actual classification rules. If necessary, official classification guidelines or historical declaration cases can also be referenced for validation.

How are the taxes and duties for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances calculated?

The taxes and duties for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances usually consist of customs duties, value-added tax , and other additional charges. The exact amount depends on the declared value and the import policies of the destination country.

What happens if the HS code 2933990092 for Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances is declared as a different HS code?

If Anastrozole, letrozole, bortezomib, temozolomide and other anticancer drug substances (HS Code: 2933990092) is declared incorrectly, it may result in customs clearance delays, tax adjustments, or compliance risks. It is recommended to correct the declaration as soon as possible or contact the customs clearance service provider for assistance. Platforms such as XTransfer can also provide declaration and risk control support to help reduce risks.